Christine Woolgar
Finanzdirektor/CFO bei Sandoz Canada, Inc.
Ursprung des Netzwerks ersten Grades von Christine Woolgar
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Christine Woolgar
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Montréal | College/University | Doctorate Degree Undergraduate Degree | |
| Toronto Metropolitan University of | College/University | Undergraduate Degree | |
Omega Laboratories Ltd.
 Omega Laboratories Ltd. Pharmaceuticals: OtherHealth Technology Part of Juno Pharmaceuticals Corp., Omega Laboratories Ltd. engages in the development, production, marketing, and distribution of medical injection and non-injection products. The company is based in Montréal, Canada. The Canadian company was founded in 1958. Omega Laboratories was acquired by Juno Pharmaceuticals Corp. from Ellimist Singapore Pte Ltd. on May 15, 2023. | Pharmaceuticals: Other | President | |
| University of Quebec | College/University | Undergraduate Degree | |
| Concordia University | College/University | Undergraduate Degree | |
| Faculté Universitaire des Sciences Agronomiques de Gembloux | College/University | Graduate Degree | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal | |
Biosimilars Canada
 Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Miscellaneous Commercial Services | Chairman |
Statistik
International
| Kanada | 7 |
| Belgien | 2 |
| Vereinigte Staaten | 2 |
Sektoral
| Consumer Services | 6 |
| Health Technology | 3 |
| Commercial Services | 2 |
Operativ
| Undergraduate Degree | 5 |
| Director/Board Member | 3 |
| President | 2 |
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Christine Woolgar
- Unternehmensverbindungen
